Study of beta2-Microglobulin Removal by Standard Versus New High Cut-Off Haemodialysis Membrane

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Renal Dialysis
Interventions
OTHER

Larger pore haemodialysis membrane

Patients receive haemodialysis sessions 3 times a week. They are randomized to start with either treatment A (experimental arm) or treatment B (active comparator arm) and continue for 2 weeks, followed by a 1-week washout period. The patients then cross-over and receive the other treatment (either B or A) for 2 weeks.

OTHER

Standard haemodialysis membrane

Patients receive haemodialysis sessions 3 times a week. They are randomized to start with either treatment A (experimental arm) or treatment B (active comparator arm) and continue for 2 weeks, followed by a 1-week washout period. The patients then cross-over and receive the other treatment (either B or A) for 2 weeks.

Trial Locations (1)

3084

Austin Health, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Austin Health

OTHER_GOV